Sandro Esteves: APHRODITE Criteria for More Targeted Male Infertility Care
Sandro Esteves, Honorary Professor of Reproductive Medicine at Aarhus University, shared a post on LinkedIn:
“Despite advances in ART, many men are still managed with oral agents prescribed without a clear endocrine rationale, often with variable and modest effects. This approach contrasts sharply with what we have learned in female reproductive medicine, where treatment evolved toward physiology-driven strategies.
In this opinion article co-authored with Peter Humaidan, we revisit that gap and argue that the field is ready for a shift.
The APHRODITE criteria integrate patient clinical characteristics, endocrine phenotype, and spermatogenic status to align treatment with underlying biology rather than empirical convention.
A key implication is the repositioning of gonadotropins—not as a last resort, but as a rational, earlier-line option in selected patients. Unlike oral agents (e.g., SERMS, AIs), gonadotropins act directly at the testicular level, restoring the physiological drivers of spermatogenesis.
This is not about replacing one treatment with another.
It is about abandoning non-stratified care.
As in ovarian stimulation, progress in male infertility will likely depend on recognizing that biological heterogeneity matters—and that treatment should follow phenotype, not habit.
The next step is clear: prospective evidence built around APHRODITE-defined phenotypes. Until then, continuing purely empirical therapy without phenotyping may no longer be justifiable.”
Title: From tablets to targeted therapy: the APHRODITE era in male infertility
Authors:Sandro C Esteves , Peter Humaidan
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 18, 2026, 11:38Inshirah Sgayer: Happy to Share Our New Publication on Unstable Fetal Lie
-
May 18, 2026, 11:27Join Us for Insightful Conversations on FRMC 2026 – Center for Human Reproduction
-
May 18, 2026, 11:19Devyanshi Dixit: PCOS and Hormonal Disorders, Advancing Precision Care in Women’s Endocrine Health
-
May 18, 2026, 11:17ASRM Responds to Supreme Court Mifepristone Decision – ASRM
-
May 18, 2026, 11:12Nibhash Kumar: Can an Intact Acrosome During ICSI Contribute to Fertilization Failure?
-
May 18, 2026, 11:05Hope Alicia: Fertility Show 2026 Highlights the Importance of Patient Support and Education
-
May 18, 2026, 11:02$10,000 Prize Announced for 2026 ASRM INNOVATE Pitch Tank Showcase – ASRM
-
May 18, 2026, 07:09Why “Just Keep Trying” is Bad Advice if You’re Under 38 with Unexplained Infertility – Fertility Plus
-
May 18, 2026, 06:37Sandro Esteves: “Merging Galaxies” at the POSEIDON and APHRODITE Conference